Top news of the week: 20.04.2022.
Companies And Industries
Better Together: Biopharma Companies Team Up Against Complex Diseases
Global biopharmaceutical companies are pooling their respective resources against difficult-to-treat tumors, CNS diseases and idiopathic pulmonary fibrosis.
Biopharma Companies Unite in Partnerships Against Cancer, IBD
Ubix Therapeutics has announced a collaboration agreement with SK Biopharmaceuticals, and Engitix and Takeda are teaming up to develop a therapeutic for fibrostenotic IBD.
Magenta Therapeutics Cuts Workforce by 14%, Shifts Focus to R&D
The revised operating plan also includes reductions in spending related to general and administrative expenses and investments in its research platform.
Will Ocugen-Bharat COVID-19 Vaccine Find a Market in North America?
Ocugen has amended its co-development, supply and commercialization deal with Bharat to include Mexico and now holds the rights for the Covaxin vaccine for all of North America.
What Regeneron’s purchase of Checkmate Pharma says about the state of biotech
Regeneron's purchase of Checkmate Pharmaceuticals is a rare buyout in biotech these days — and says a lot about the state of the industry.
BioSpace Movers & Shakers, April 15: Spruce, Nautilus, Alto, Ikena Oncology
BioSpace Movers & Shakers, April 15: Spruce, Nautilus, Alto, Ikena Oncology - read this article along with other careers information, tips and advice on BioSpace
Clinical Catch-Up: AACR, AAN and COVID-19
It was a very busy week for clinical trial news, with much of it coming out of the American Association of Cancer Research Annual Meeting. Read on for details.
The Integral Role of HiFi Sequencing in Discovering What Makes Us Human
Scientists recently announced the complete sequencing of the entire human genome. Biotech company PacBio - and HiFi sequencing - played a big role in this milestone.